A major advance in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in many forms of tumors, causing https://bookmarksden.com/story22142534/vhh-fragments-reactivate-tumor-suppressor-p53-new-potential-hope-for-malignant-therapy